Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (SHA:603811)
China · Delayed Price · Currency is CNY 11.05
-0.10 (-0.90%)
May 21, 2026, 3:00 PM CST
SHA:603811 Market Cap
SHA:603811 has a market cap or net worth of 3.51 billion as of May 21, 2026. Its market cap has increased by 28.75% in one year.
Market Cap
3.51B
Enterprise Value
3.30B
Revenue
790.86M
Ranking
n/a
PE Ratio
15.77
Stock Price
11.05
Market Cap Chart
Since March 15, 2017, SHA:603811's market cap has increased from 1.93B to 3.51B, an increase of 81.59%. That is a compound annual growth rate of 6.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 3.54B | 6.19% |
| Dec 31, 2025 | 3.34B | 32.01% |
| Dec 31, 2024 | 2.53B | -25.55% |
| Dec 29, 2023 | 3.39B | 3.77% |
| Dec 30, 2022 | 3.27B | -13.80% |
| Dec 31, 2021 | 3.79B | -1.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Mar 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Qianjiang Yongan Pharmaceutical | 3.71B |
| Nanjing Well Pharmaceutical Group | 3.65B |
| Hunan Hansen Pharmaceutical | 3.60B |
| ShanXi C&Y Pharmaceutical Group Co.,LTD. | 3.58B |
| Huaren Pharmaceutical | 3.56B |
| Tibet AIM Pharm. | 3.56B |
| Harbin Medisan Pharmaceutical | 3.49B |
| Tuoxin Pharmaceutical Group | 3.44B |